• Werewolf Therapeutics' (HOWL) Outperform Rating Reiterated at Wedbush

    Source: Buzz FX / 13 Mar 2025 11:11:16   America/Chicago


    Werewolf Therapeutics' (HOWL) Outperform Rating Reiterated at Wedbush Written by MarketBeat March 13, 2025 Share Link copied to clipboard. Remove Ads Werewolf Therapeutics ( NASDAQ:HOWL - Get Free Report ) 's stock had its "outperform" rati
    Read more...
Share on,